about
New enumeration algorithm for protein structure comparison and classificationBridger: a new framework for de novo transcriptome assembly using RNA-seq data.SPARCoC: a new framework for molecular pattern discovery and cancer gene identificationEnhancing cancer clonality analysis with integrative genomics.Bi-allelic inactivation is more prevalent at relapse in multiple myeloma, identifying RB1 as an independent prognostic marker.Spatial genomic heterogeneity in multiple myeloma revealed by multi-region sequencing.Clonal selection and double-hit events involving tumor suppressor genes underlie relapse in myeloma.eMBI: Boosting Gene Expression-based Clustering for Cancer Subtypes.The level of deletion 17p and bi-allelic inactivation of TP53 has a significant impact on clinical outcome in multiple myeloma.Loss of heterozygosity as a marker of homologous repair deficiency in multiple myeloma: a role for PARP inhibition?Identification of novel mutational drivers reveals oncogene dependencies in multiple myelomaPoor overall survival in hyperhaploid multiple myeloma is defined by double-hit bi-allelic inactivation ofA high-risk, Double-Hit, group of newly diagnosed myeloma identified by genomic analysisCombination of flow cytometry and functional imaging for monitoring of residual disease in myeloma.DNAp: A Pipeline for DNA-seq Data AnalysisClonal evolution in myeloma: the impact of maintenance lenalidomide and depth of response on the genetics and sub-clonal structure of relapsed disease in uniformly treated newly diagnosed patientsTarPan: an easily adaptable targeted sequencing panel viewer for research and clinical useMicrohomology-mediated end joining drives complex rearrangements and overexpression of MYC and PVT1 in multiple myelomaThe genomic landscape of plasma cells in systemic light chain amyloidosisGenomic analysis of primary plasma cell leukemia reveals complex structural alterations and high-risk mutational patterns
P50
Q21093382-197DEF74-8400-48FF-86C7-E9362AA267C8Q30901343-7149D224-F1EB-4F20-B2F5-4E4E1C4B13E4Q35175659-7A3778D2-41EC-4707-A666-2CE2891FB8F9Q35794451-D25EB9A6-1F98-48E8-A2BD-34AF085EE39AQ37744796-A2E11BE1-0758-44CC-969E-75DD75A20B0DQ41436943-66AC6599-EB59-4BC4-82F0-AF8419AFC7B4Q41663752-5E91FE4B-A0F0-4FB3-8505-61266DA30652Q42967077-7CC92BD2-080A-410E-85F9-A2A969B8920AQ47165099-A5C70A6A-BFA8-4D1B-A4D5-9157DC75CD9DQ52691505-16D022C3-C019-4C21-812F-D0991608EEA6Q58792995-E27ED179-775F-45FC-B4C5-4FE0743A9CC5Q61811959-8D83508A-1946-4694-ACF3-EC3F6C74BBEFQ61905635-5AC96086-9453-4CD1-8261-3C3563FA16BDQ64929020-320BF840-CB37-4F04-BE94-27717DB04888Q88538181-914BED1C-D030-4B88-B24E-EB102FE94CBFQ91409167-5A6F3906-413A-4896-922B-BEC509F89042Q91949142-5441F47D-943D-48E8-9979-1B50EC4BADF8Q92916912-45062A35-5219-4857-9BC5-82D0B3F48A23Q93182963-30A2C816-BD4B-452B-B7A9-5D4B40988DAAQ96576366-E53C5FD3-8759-4C77-BFE8-A7269741D3B3
P50
description
researcher ORCID ID = 0000-0002-9361-0283
@en
wetenschapper
@nl
name
Cody Ashby
@ast
Cody Ashby
@en
Cody Ashby
@es
Cody Ashby
@nl
type
label
Cody Ashby
@ast
Cody Ashby
@en
Cody Ashby
@es
Cody Ashby
@nl
prefLabel
Cody Ashby
@ast
Cody Ashby
@en
Cody Ashby
@es
Cody Ashby
@nl
P106
P31
P496
0000-0002-9361-0283